Dr. Antonella Santuccione Chadha is a medical doctor with expertise in clinical pathology, neuroscience and psychiatric disorders. She is Chief medical officer at Altoida inc. In 2016 she co-founded and pro-bono CEO of the non-profit organization “Women’s Brain Project” which is addressing the influence of sex and gender on mental and brain diseases. Since then, she acts the pro bono CEO of the organization. Antonella has decades of experience in preclinical research, patient treatment, clinical development, medical affairs and international regulatory framework for therapeutics.
Always focused on solving the puzzles related to Alzheimer’s and other psychiatric diseases, she studied possible immunotherapies for AD in the laboratory of Roger Nitsch and Christoph Hock at the university of Zurich where aducanumab, the first amyloid treatment for Alzheimer’s disease was discovered. She also worked with Swissmedic, Roche diagnostic and Roche Pharma, Biogen, several European Universities, the EU Commission Directorate for Health and Food Safety, the OECD, the CEOi and several Alzheimer’s’ disease Organizations. Since 2018 she is listed among the top 100 Women in Business in Switzerland and in 2019, she has been elected Woman of the Year in Switzerland by the Magazine “Women in Business”.
In 2020, she received the World Sustainability Award for her involvement in advancing Precision Medicine. She also received the award “Premio Medicina Italia” for her contribution to the management of the pandemic.
In 2021 she has been acknowledged among the “Women for Innovation” in Switzerland from the University of Basel and received the N.1 award from the Italian Embassy for her contribution to the cooperation between Switzerland and Italy.
In 2022, she was awarded the “Veuve Clicquot Bold Woman Award” in Switzerland.
She is the Vice-president of Euresearch and acts as a scientific advisor for several start-up and scientific institutions.
Dr. Santuccione Chadha is keenly interested in removing bias when developing solutions for mental and neurological diseases to achieve precision medicines and she is advocating for the first worldwide sex and gender precision medicine research institute based in Switzerland.
She is the author of several scientific publications, TEDx and books, among them “Sex and Gender Differences in Alzheimer’s disease” and “Una Bambina Senza Testa” which will become a TV series.
